Aralez Bio is a platform technology company with a proprietary enzymatic approach for designing and manufacturing noncanonical amino acids (ncAAs)
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/30/24 | $12,000,000 | Series A |
Astia Ventures Freeflow Ventures Good Growth Capital Heritage Medical Systems Impact Science Ventures Juniper Ventures Paladin Capital Group Pineapple Group Spero Ventures  | undisclosed |
